Navigation Links
Startup Nanotech Firm Books First Revenue From Large Chip Makers
Date:7/30/2008

Carbon Nanoprobes, Inc. receives custom orders from leading semiconductor manufacturers, officially putting revenue on the company's books.

Seattle, WA (PRWEB) July 30, 2008 -- Carbon Nanoprobes, Inc (www.cnprobes.com [CN Probes™]), an emerging nanotech solutions provider, welcomes its first revenue from two major semiconductor manufacturers. Contracts with major semiconductor companies are a huge milestone for CN Probes. Coupled with these orders is the excitement relayed in a recent press release detailing an outsourced production agreement. Brian Ruby, CN Probes' founder and CEO, comments "these custom orders are taking place before our outsourced manufacturing line goes into full production. It's an exciting display of traction and market acceptance when your clients have such high-value applications that they will pay you to do custom work before you are in full-scale production "

Says Ruby, "this is an exciting day many years in the making. We're humbled to be counted among a narrow group of nanotechnology companies who have booked revenue. Although significant milestones need to be met in the future, we are encouraged to begin making the transition from a research and development company to a sales and marketing focused organization. Booking this revenue is the official 'kick-off' of a transition numerous nanotechnology firms never achieve."

CN Probes is developing a highly economic, proprietary, scalable, and flexible manufacturing process of a carbon nanotube probe tip for use in the atomic force microscope (AFM). This process alleviates the current production woes of carbon nanotube AFM tips. Their tips empower advanced imaging technology, improving the way researchers conduct their research - accelerating the speed and enhancing the quality of their results.
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. RainDance Announces Company Relocation and Manufacturing Startup
2. Local officials move toward monitoring nanotechnologies
3. Nanotech: A regulatory blueprint for the next administration
4. Using nanotechnology to create high-performance materials
5. Nanotechnology: Learning from past mistakes
6. Nanotechnology oversight: An agenda for the new administration
7. Advance Nanotechs Owlstone Subsidiary Receives a $629,000 Order From Selex Galileo
8. Joint nanotechnology forum to focus on electronics, photonics, renewable energy
9. Advance Nanotechs Owlstone Subsidiary Receives Order From IEE
10. Advance Nanotechs Owlstone Subsidiary Selected as One of Four Finalists in The 2008 Royal Academy of Engineering MacRobert Awards Competition
11. NASA Nanotechnology-Based Biosensor Helps Detect Biohazards
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Startup Nanotech Firm Books First Revenue From Large Chip Makers 
(Date:5/21/2015)... ANGELES , May 21, 2015  CytRx ... and development company specializing in oncology, today announced ... clinical trial with aldoxorubicin for the treatment of ... brain cancer.  The open-label, multisite trial is designed ... aldoxorubicin in patients whose tumors have progressed following ...
(Date:5/21/2015)... Ontario (PRWEB) May 21, 2015 ... into an exclusive North American distribution agreement with ... testing system. , With more than 160 years ... products and services for laboratory and production facilities, ... operational excellence and differentiated services to enable science. ...
(Date:5/20/2015)... This year has been one of the ... Patented Pearl’s Premium Ultra Low Maintenance Lawn Seed comes ... are coming out of record bad weather. Offering ... global concerns related to water, health, and climate change, ... to the standard, water-wasting, chemical-treated standard lawn. Many ...
(Date:5/20/2015)... , May 20, 2015  Health eCareers, ... short-staffed healthcare organizations with job seekers looking for ... , a new mobile and online tool dedicated ... healthcare industry. SHIFT enables employers to ... tenens, travel nursing, per diem and other temporary ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 3
... , GAITHERSBURG, Md., Aug. 6 GenVec, Inc. (Nasdaq: ... quarter ended June 30, 2009. , , ... GenVec reported a net loss of $4.8 million ($0.05 per ... net loss of $6.6 million ($0.08 per share) in the comparable quarter ...
... , ROCKVILLE, Md., Aug. 6 Novavax, Inc. ... Frederick W. Driscoll as Vice President, Chief Financial Officer and ... Novavax,s President and Chief Executive Officer. , , ... President and Chief Executive Officer of Genelabs Technologies, Inc. ...
... , NEWTON, Mass., Aug. 6 Microfluidics International ... release second quarter 2009 financial results on Tuesday, August 11, ... , Michael C. Ferrara, President and Chief Executive Officer, ... Officer, will host a conference call and live audio webcast at ...
Cached Biology Technology:GenVec Reports Second Quarter 2009 Financial Results 2GenVec Reports Second Quarter 2009 Financial Results 3GenVec Reports Second Quarter 2009 Financial Results 4GenVec Reports Second Quarter 2009 Financial Results 5GenVec Reports Second Quarter 2009 Financial Results 6GenVec Reports Second Quarter 2009 Financial Results 7Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer 2Microfluidics International Corporation to Report Second Quarter 2009 Financial Results on August 11, 2009 2
(Date:5/11/2015)... May 11, 2015  Synaptics Incorporated (NASDAQ: ... solutions, today announced the appointment of Wajid ... Financial Officer, reporting to Rick Bergman , ... Chief Financial Officer, Kathleen Bayless , who ... Mr. Ali brings extensive financial management expertise ...
(Date:5/11/2015)... 11, 2015 Curemark LLC, a privately held ... a new Phase III double blind, randomized, placebo-controlled clinical ... CM-AT, on all children ages 3-8 with Autism. Previously, ... III double blinded clinical trial for CM-AT in children ... the digestive enzyme chymotrypsin. This new trial will help ...
(Date:5/8/2015)... May 8, 2015 Synaptics Inc. (NASDAQ: SYNA ... that members of the executive management team will present at ... Technology, Media and Telecom Conference Date: May 18, 2015 ... Boston, MA Cowen and Company ... 2:45pm ET Location: The New York Palace Hotel, ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2
... at The University of Queensland could contribute to the ... virus and Dengue fever. Led by Associate ... School of Molecular and Microbial Sciences identified a novel ... belong. The team found all flaviviruses produced ...
... Harbor, N.Y. Much like cancer cells, plant cells ... milieu, in culture dishes, have highly unstable genomes. Changes ... cells cope with challenging culture conditions but inadvertently also ... of DNA that can jump around in the genome, ...
... can have genetic causes. Researchers at the Institute of ... correlation. The causes of what is known as irritable ... of the gastrointestinal tract, are considered unclear making ... which were published in the prestigious jour-nal " Human ...
Cached Biology News:UQ research targets West Nile virus and dengue fever 2CSHL researchers map changing epigenetic modifications that enable transposons to run amok 2Irritable bowel syndrome can have genetic causes 2
... are used to study co-translational and ... events such as signal peptide cleavage, ... can be examined by the translation ... in the presence of these microsomal ...
... using Mo Bio luciferase assay. Mo Bio Laboratories ... will allow you to certify your products ATP-Free ... you to deliver them to your customers in ... limit is 3.5 x 10-12 /l, which will ...
... Microarrays: Biomedical Photometrics Inc. (Waterloo, Ontario, Canada) ... have collaborated to develop a fluorescence reader ... The DNAscope AT is based on BPIs ... automatically reads up to six ArrayTubes in ...
... Sciences provides a comprehensive kinase analysis ... substrate (PKS) peptide microarrays synthesized on ... kinase profiling, quantitative measurement of kinase ... This comprehensive service includes preparation of ...
Biology Products: